Effect of risk of malnutrition on 30-day mortality among older patients with acute heart failure in Emergency Departments.


Journal

European journal of internal medicine
ISSN: 1879-0828
Titre abrégé: Eur J Intern Med
Pays: Netherlands
ID NLM: 9003220

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 26 01 2019
revised: 19 03 2019
accepted: 23 04 2019
pubmed: 12 5 2019
medline: 17 9 2020
entrez: 12 5 2019
Statut: ppublish

Résumé

Little is known about the prevalence and impact of risk of malnutrition on short-term mortality among seniors presenting with acute heart failure (AHF) in emergency setting. The objective was to determine the impact of risk of malnutrition on 30-day mortality risk among older patients who attended in Emergency Departments (EDs) for AHF. We performed a secondary analysis of the OAK-3 Registry including all consecutive patients ≥65 years attending in 16 Spanish EDs for AHF. Risk of malnutrition was defined by the Mini Nutritional Assessment Short Form (MNA-SF) < 12 points. Unadjusted and adjusted logistic regression models were used to assess the association between risk of malnutrition and 30-day mortality. We included 749 patients (mean age: 85 (SD 6); 55.8% females). Risk of malnutrition was observed in 594 (79.3%) patients. The rate of 30-day mortality was 8.8%. After adjusting for MEESSI-AHF risk score clinical categories (model 1) and after adding all variables showing a significantly different distribution among groups (model 2), the risk of malnutrition was an independent factor associated with 30-day mortality (adjusted OR by model 1 = 3.4; 95%CI 1.2-9.7; p = .020 and adjusted OR by model 2 = 3.1; 95%CI 1.1-9.0; p = .033) compared to normal nutritional status. The risk of malnutrition assessed by the MNA-SF is associated with 30-day mortality in older patients with AHF who were attended in EDs. Routine screening of risk of malnutrition may help emergency physicians in decision-making and establishing a care plan.

Sections du résumé

BACKGROUND BACKGROUND
Little is known about the prevalence and impact of risk of malnutrition on short-term mortality among seniors presenting with acute heart failure (AHF) in emergency setting. The objective was to determine the impact of risk of malnutrition on 30-day mortality risk among older patients who attended in Emergency Departments (EDs) for AHF.
MATERIAL AND METHODS METHODS
We performed a secondary analysis of the OAK-3 Registry including all consecutive patients ≥65 years attending in 16 Spanish EDs for AHF. Risk of malnutrition was defined by the Mini Nutritional Assessment Short Form (MNA-SF) < 12 points. Unadjusted and adjusted logistic regression models were used to assess the association between risk of malnutrition and 30-day mortality.
RESULTS RESULTS
We included 749 patients (mean age: 85 (SD 6); 55.8% females). Risk of malnutrition was observed in 594 (79.3%) patients. The rate of 30-day mortality was 8.8%. After adjusting for MEESSI-AHF risk score clinical categories (model 1) and after adding all variables showing a significantly different distribution among groups (model 2), the risk of malnutrition was an independent factor associated with 30-day mortality (adjusted OR by model 1 = 3.4; 95%CI 1.2-9.7; p = .020 and adjusted OR by model 2 = 3.1; 95%CI 1.1-9.0; p = .033) compared to normal nutritional status.
CONCLUSIONS CONCLUSIONS
The risk of malnutrition assessed by the MNA-SF is associated with 30-day mortality in older patients with AHF who were attended in EDs. Routine screening of risk of malnutrition may help emergency physicians in decision-making and establishing a care plan.

Identifiants

pubmed: 31076345
pii: S0953-6205(19)30120-7
doi: 10.1016/j.ejim.2019.04.014
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-77

Informations de copyright

Copyright © 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Auteurs

Francisco Javier Martín-Sánchez (FJ)

Emergency Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Electronic address: fmarti09@ucm.es.

Federico Cuesta Triana (F)

Universidad Complutense de Madrid, Madrid, Spain; Department of Geriatric Medicine, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Xavier Rossello (X)

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Rebeca Pardo García (R)

Universidad Complutense de Madrid, Madrid, Spain.

Guillermo Llopis García (G)

Emergency Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Francisca Caimari (F)

Department of Endocrinology, University College London, Hospitals NHS Foundation Trust, London, UK.

María Teresa Vidán (MT)

Universidad Complutense de Madrid, Madrid, Spain; Department of Geriatric Medicine, Hospital General Universitario Gregorio Marañón, Instituto de Investigación IiSGM, Universidad Complutense de Madrid, Madrid, Spain.

Pedro Ruiz Artacho (P)

Department of Internal Medicine, Clínica Universitaria de Navarra, Madrid, Spain.

Juan González Del Castillo (J)

Emergency Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.

Pere Llorens (P)

Emergency Department-UCE-UHD, Hospital General Universitario de Alicante, Alicante, Spain.

Pablo Herrero (P)

Emergency Department, Hospital Central de Asturias, Oviedo, Asturias, Spain.

Javier Jacob (J)

Emergency Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Víctor Gil (V)

Emergency Department, Hospital Clínic, Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Cristina Fernández Pérez (C)

Universidad Complutense de Madrid, Madrid, Spain; Preventive Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Pedro Gil (P)

Universidad Complutense de Madrid, Madrid, Spain; Department of Geriatric Medicine, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Héctor Bueno (H)

Universidad Complutense de Madrid, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Department of Cardiology, Instituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.

Òscar Miró (Ò)

Emergency Department, Hospital Clínic, Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Pilar Matía Martín (P)

Universidad Complutense de Madrid, Madrid, Spain; Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Esther Rodríguez Adrada (E)

Hospital Clínico San Carlos, Madrid, Spain.

María Carmen Santos (MC)

Hospital Clínico San Carlos, Madrid, Spain.

Lucía Salgado (L)

Hospital Clínico San Carlos, Madrid, Spain.

Berenice Nayla Brizzi (BN)

Hospital Clínico San Carlos, Madrid, Spain.

María Luisa Docavo (ML)

Hospital Clínico San Carlos, Madrid, Spain.

María Del Mar Suárez-Cadenas (M)

Hospital Clínico San Carlos, Madrid, Spain.

Carolina Xipell (C)

Hospital Clínic, Barcelona, Spain.

Carolina Sánchez (C)

Hospital Clínic, Barcelona, Spain.

Sira Aguiló (S)

Hospital Clínic, Barcelona, Spain.

Josep María Gaytan (JM)

Hospital Clínic, Barcelona, Spain.

Alba Jerez (A)

Hospital Clínic, Barcelona, Spain.

María José Pérez-Durá (MJ)

Hospital La Fe, Valencia, Spain.

Pablo Berrocal Gil (P)

Hospital La Fe, Valencia, Spain.

María Luisa López-Grima (ML)

Hospital Dr. Peset, Valencia, Spain.

Amparo Valero (A)

Hospital Dr. Peset, Valencia, Spain.

Alfons Aguirre (A)

Hospital del Mar, Barcelona, Spain.

Maria Àngels Pedragosa (MÀ)

Hospital del Mar, Barcelona, Spain.

Pascual Piñera (P)

Hospital Reina Sofía, Murcia, Spain.

Paula LázaroAragues (P)

Hospital Reina Sofía, Murcia, Spain.

José Andrés Sánchez Nicolás (JA)

Hospital Reina Sofía, Murcia, Spain.

Miguel Alberto Rizzi (MA)

Hospital de la Santa Creu y Sant Pau, Barcelona, Spain.

Sergio Herrera Mateo (S)

Hospital de la Santa Creu y Sant Pau, Barcelona, Spain.

Aitor Alquezar (A)

Hospital de la Santa Creu y Sant Pau, Barcelona, Spain.

Alex Roset (A)

Hospital Universitari de Bellvitge, Barcelona, Spain.

Carles Ferrer (C)

Hospital Universitari de Bellvitge, Barcelona, Spain.

Ferrán Llopis (F)

Hospital Universitari de Bellvitge, Barcelona, Spain.

José María Álvarez Pérez (JM)

Hospital Universitario, Burgos, Spain.

María Pilar López Diez (MP)

Hospital Universitario, Burgos, Spain.

Fernando Richard (F)

Hospital Universitario, Burgos, Spain.

José María Fernández-Cañadas (JM)

Hospital Universitario General de Alicante, Alicante, Spain.

José Manuel Carratalá (JM)

Hospital Universitario General de Alicante, Alicante, Spain.

Patricia Javaloyes (P)

Hospital Universitario General de Alicante, Alicante, Spain.

Juan Antonio Andueza (JA)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

José Antonio Sevillano Fernández (JA)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Rodolfo Romero (R)

Hospital Getafe, Madrid, Spain.

Marta Merlo Loranca (M)

Hospital Getafe, Madrid, Spain.

Virginia Álvarez Rodríguez (V)

Hospital Getafe, Madrid, Spain.

María Teresa Lorca (MT)

Hospital del Tajo, Madrid, Spain.

Luis Calderón (L)

Hospital del Tajo, Madrid, Spain.

Ester Soy Ferrer (E)

Hospital JosepTrueta, Girona, Spain.

José Manuel Garrido (J)

Hospital Virgen de la Macarena, Sevilla, Spain.

Enrique Martín Mojarro (E)

Hospital Sant Pau i Santa Tecla, Tarragona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH